Great 4C cashflow. Far better than expected. The management of IBN are motivated.From the top down all are paid with a high component of commission for sale even the MD. This motivates employees to go the extra mile for the sale.We will see how the market reacts over the coming period but you would expect it to be upwards as the story unfolds.
- Forums
- ASX - By Stock
- TI1
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-25
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TI1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.21M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TI1 (ASX) Chart |
Day chart unavailable
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online